IonQ (NYSE:IONQ) Insider Sells $89,564.47 in Stock

IonQ, Inc. (NYSE:IONQ) insider John Raymond sold 2,407 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $37.21, for a total value of $89,564.47. Following the completion of the transaction, the insider owned 77,741 shares of the company’s stock, valued at approximately $2,892,742.61. This trade represents a 3.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

IonQ Stock Down 0.2%

Shares of IONQ stock traded down $0.07 during mid-day trading on Friday, reaching $36.77. 15,323,048 shares of the company’s stock traded hands, compared to its average volume of 17,757,170. The company’s 50-day moving average price is $39.92 and its 200-day moving average price is $43.70. The company has a market cap of $14.01 billion, a P/E ratio of -7.89 and a beta of 3.30. IonQ, Inc. has a 12 month low of $25.89 and a 12 month high of $84.64.

IonQ (NYSE:IONQ) last posted its quarterly earnings data on Wednesday, August 5th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.56) by $0.23. IonQ had a negative net margin of 553.27% and a negative return on equity of 22.29%. The business had revenue of $80.05 million for the quarter, compared to analyst estimates of $66.47 million. During the same quarter in the previous year, the firm posted ($0.70) earnings per share. IonQ’s quarterly revenue was up 286.7% on a year-over-year basis. Equities analysts predict that IonQ, Inc. will post -2.86 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Needham & Company LLC reissued a “buy” rating and issued a $65.00 target price on shares of IonQ in a report on Wednesday. Rosenblatt Securities reaffirmed a “buy” rating and issued a $100.00 price target on shares of IonQ in a research report on Wednesday. Mizuho dropped their price target on shares of IonQ from $61.00 to $52.00 and set an “outperform” rating on the stock in a research note on Wednesday. Cantor Fitzgerald reissued an “overweight” rating and set a $70.00 price objective on shares of IonQ in a research report on Wednesday. Finally, Jefferies Financial Group restated a “buy” rating and set a $80.00 price objective on shares of IonQ in a research note on Wednesday. Ten equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $67.17.

Key Headlines Impacting IonQ

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: IonQ raised its 2026 revenue outlook to $450 million–$460 million, with the increase supported partly by its SkyWater acquisition. Higher guidance strengthens the company’s growth narrative, although acquisition-related contributions may limit the organic-growth benefit. IonQ Raises 2026 Revenue Guidance
• Positive Sentiment: IonQ unveiled Superion 256, a 256-qubit quantum processing unit, along with plans for faster chip development and data-center deployment targeted for 2027. The announcement may support expectations for commercial adoption and technological leadership. IonQ Advances Quantum Computing With Superion 256
• Positive Sentiment: Rosenblatt Securities and Needham reiterated Buy ratings, while Cantor Fitzgerald reaffirmed an Overweight rating, indicating that several analysts remain constructive on IonQ’s long-term opportunity. Rosenblatt Reiterates Buy Rating
• Neutral Sentiment: Investor-focused coverage highlighted IonQ’s position in quantum-computing accuracy and its potential to benefit from cybersecurity demand. These articles are largely opinion-based rather than new financial disclosures. If I Could Only Buy One Quantum Computing Stock
• Negative Sentiment: Mizuho analyst Vijay Rakesh cut his price target to $52 from $61 after IonQ’s Analyst Day, despite maintaining a Buy rating. The reduction suggests the updated outlook did not fully satisfy expectations. Why IonQ Stock Is Down
• Negative Sentiment: Critical coverage questioned whether IonQ’s long-term quantum opportunity is sufficiently supported by near-term financial results. IonQ remains unprofitable, and its elevated valuation makes the stock particularly sensitive to execution concerns and changing investor expectations. Why IonQ’s Quantum Story Still Isn’t Convincing

Institutional Investors Weigh In On IonQ

Institutional investors have recently modified their holdings of the business. California State Teachers Retirement System lifted its stake in IonQ by 5,901.1% during the 2nd quarter. California State Teachers Retirement System now owns 28,318,821 shares of the company’s stock valued at $1,508,260,000 after acquiring an additional 27,846,924 shares during the period. BlackRock Inc. bought a new position in IonQ during the second quarter valued at approximately $1,112,945,000. State Street Corp boosted its holdings in IonQ by 42.3% in the fourth quarter. State Street Corp now owns 8,962,789 shares of the company’s stock worth $402,160,000 after purchasing an additional 2,663,230 shares during the last quarter. Geode Capital Management LLC boosted its holdings in IonQ by 21.9% in the fourth quarter. Geode Capital Management LLC now owns 8,074,301 shares of the company’s stock worth $361,624,000 after purchasing an additional 1,452,463 shares during the last quarter. Finally, Bank of America Corp DE bought a new stake in IonQ in the 2nd quarter worth approximately $344,757,000. 41.42% of the stock is owned by hedge funds and other institutional investors.

About IonQ

IonQ, Inc is a quantum computing company that develops and commercializes quantum computers based on trapped-ion technology. Its systems are designed to perform specialized computations that may be difficult for classical computers, with potential applications in areas such as optimization, materials science, drug discovery, artificial intelligence and financial modeling.

The company provides access to its quantum processors through cloud platforms, including Amazon Web Services’ Amazon Braket, Microsoft Azure Quantum and Google Cloud.